JB Chemicals & Pharmaceuticals Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.095x

JB Chemicals & Pharmaceuticals Limited cash flow conversion efficiency. Based on the latest financial reports, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has a cash flow conversion efficiency ratio of 0.095x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.62 Billion ≈ $39.19 Million USD) by net assets (Rs38.06 Billion ≈ $411.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of JB Chemicals & Pharmaceuticals Limited (2006–2026)

Cash flow conversion efficiency of JB Chemicals & Pharmaceuticals Limited from 2006 to 2026. This chart illustrates how JB Chemicals & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for JB Chemicals & Pharmaceuticals Limited for real-time trading data and today's change.

JB Chemicals & Pharmaceuticals Limited Cash Flow Conversion Ratio Explained

JB Chemicals & Pharmaceuticals Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

JB Chemicals & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of JB Chemicals & Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Also see market value of JB Chemicals & Pharmaceuticals Limited for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
SICC Co. Ltd.
SHG:688234
-0.030x
Grupo Simec S.A.B. de C.V
MX:SIMECB
-0.007x
De Grey Mining Ltd
AU:DEG
0.000x
Hindustan Copper Limited
NSE:HINDCOPPER
0.128x
Sinopec Oilfield Service Corp
SHG:600871
0.368x
FTI Consulting Inc
NYSE:FCN
0.114x
Hongda
SHG:600331
-0.083x
Northland Power Inc.
TO:NPI
0.037x

Annual Cash Flow Conversion Efficiency for JB Chemicals & Pharmaceuticals Limited (2006–2026)

The table below shows the annual cash flow conversion efficiency of JB Chemicals & Pharmaceuticals Limited from 2006 to 2026. Review JBCHEPHARM cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs41.59 Billion
≈ $449.80 Million
Rs7.11 Billion
≈ $76.85 Million
0.171x -35.00%
2025-03-31 Rs34.33 Billion
≈ $371.30 Million
Rs9.02 Billion
≈ $97.60 Million
0.263x -4.02%
2024-03-31 Rs29.23 Billion
≈ $316.15 Million
Rs8.01 Billion
≈ $86.58 Million
0.274x +8.58%
2023-03-31 Rs24.80 Billion
≈ $268.24 Million
Rs6.26 Billion
≈ $67.66 Million
0.252x +217.05%
2022-03-31 Rs21.39 Billion
≈ $231.28 Million
Rs1.70 Billion
≈ $18.40 Million
0.080x -54.17%
2021-03-31 Rs18.13 Billion
≈ $196.12 Million
Rs3.15 Billion
≈ $34.04 Million
0.174x -9.35%
2020-03-31 Rs14.38 Billion
≈ $155.51 Million
Rs2.75 Billion
≈ $29.78 Million
0.191x +47.08%
2019-03-31 Rs14.83 Billion
≈ $160.37 Million
Rs1.93 Billion
≈ $20.88 Million
0.130x +52.83%
2018-03-31 Rs14.44 Billion
≈ $156.20 Million
Rs1.23 Billion
≈ $13.31 Million
0.085x -41.88%
2017-03-31 Rs13.66 Billion
≈ $147.71 Million
Rs2.00 Billion
≈ $21.65 Million
0.147x +14.95%
2016-03-31 Rs10.95 Billion
≈ $118.46 Million
Rs1.40 Billion
≈ $15.10 Million
0.128x +0.15%
2015-03-31 Rs9.95 Billion
≈ $107.59 Million
Rs1.27 Billion
≈ $13.70 Million
0.127x +1049.86%
2014-03-31 Rs10.43 Billion
≈ $112.78 Million
Rs-139.78 Million
≈ $-1.51 Million
-0.013x -116.10%
2013-03-31 Rs10.20 Billion
≈ $110.34 Million
Rs849.32 Million
≈ $9.19 Million
0.083x -90.82%
2012-03-31 Rs9.70 Billion
≈ $104.90 Million
Rs8.80 Billion
≈ $95.14 Million
0.907x +368.67%
2011-03-31 Rs6.92 Billion
≈ $74.79 Million
Rs1.34 Billion
≈ $14.47 Million
0.194x -9.87%
2010-03-31 Rs5.68 Billion
≈ $61.44 Million
Rs1.22 Billion
≈ $13.19 Million
0.215x +10.50%
2009-03-31 Rs4.69 Billion
≈ $50.71 Million
Rs911.05 Million
≈ $9.85 Million
0.194x +210.91%
2008-03-31 Rs4.53 Billion
≈ $48.99 Million
Rs283.11 Million
≈ $3.06 Million
0.062x +17.36%
2007-03-31 Rs4.18 Billion
≈ $45.26 Million
Rs222.82 Million
≈ $2.41 Million
0.053x -21.99%
2006-03-31 Rs3.30 Billion
≈ $35.73 Million
Rs225.51 Million
≈ $2.44 Million
0.068x --

About JB Chemicals & Pharmaceuticals Limited

NSE:JBCHEPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$4.18 Billion
Rs386.77 Billion INR
Market Cap Rank
#3904 Global
#174 in India
Share Price
Rs2408.90
Change (1 day)
-3.87%
52-Week Range
Rs1691.80 - Rs2506.00
All Time High
Rs2506.00
About

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dos… Read more